// App-Quantinova.ai

4125 : PANOVA: A pilot study of TTFields concomitant with gemcitabine for front-line therapy of advanced pancreatic adenocarcinoma.

Researchers

Presenter

  • Fernando Rivera

Principal Investigators

  • Javier Gallego

  • Carmen Guillen

  • Manuel Benavides

  • Jose A. Lopez-Martin

  • Marc Kueng

Medical Centers

  • Hospital Universitario Marques de Valdecilla, Santander, Cantabria, Spain

  • Servicio de Oncologia Medica, Hospital General Universitario de Elche, Elche, Spain

  • Medical Oncology Department, Ramon y Cajal University Hospital, IRYCIS, RETICC of Spanish Ministry of Science and Innovation, Madrid, Spain

  • Fimabis, Fuengirola, Spain

  • '12 de Octubre' University Hospital & Research Institute, Madrid, Spain

  • Cantonal Hospital Fribourg, Fribourg, Switzerland

Locations

  • Spain

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreatic cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Gemcitabine

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • NCT01971281

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved